N-substituted benzamides inhibit NFκB activation and induce apoptosis by separate mechanisms by Liberg, D et al.
Apoptosis, or programmed cell death, is a mechanism for physio-
logical elimination of cells during development or tissue reactions.
Apoptosis may be triggered via many different environmental
stimuli whose intracellular signalling pathways converge at the
level of activation of caspases (Cohen, 1997). These cysteine
proteases cleave various substrates that are critical for cell
integrity, and also release specific nucleases that are responsible
for the characteristic DNA fragmentation connected to apoptotic
cell death (Enari et al, 1998; Sakahira et al, 1998). The possibility
to selectively trigger apoptosis in transformed cells as a strategy
for cancer treatment is an attractive approach and the focus of
intense drug development efforts.
The NFkB signalling pathway (reviewed in Ghosh et al, 1998)
has also been the subject of intense study as a drug target. From its
initial description as a transcription factor for the immunoglobulin
klocus (Sen and Baltimore, 1986), this multimember family of
transcriptional activators has been implicated in a large number of
biological mechanisms in both health and disease (reviewed in
Baeuerle and Baltimore, 1996; Baldwin, 1996). Recently, it was
also shown that NFkB was involved in the regulation of apoptotic
cell death (Beg and Baltimore, 1996; Liu et al, 1996; Van Antwerp
et al, 1996; Wang et al, 1996; Wu et al, 1996). Hence, if NFkB
activation was blocked, cells that had received an apoptotic stim-
ulus showed a more pronounced response than a corresponding
cell population where the NFkB activation pathway was intact
(Beg and Baltimore, 1996; Van Antwerp et al, 1996; Wang et al,
1996). This salvage pathway from apoptotic cell death can thus be
seen as a potential mechanism for the survival of tumour cells and
inhibition of NFkB activation may thus be a means to treat malig-
nant disease.
Benzamides have been exploited in the clinic as anti-emetics,
anti-psychotics, anti-arrhythmics, local anaesthetics, anti-inflam-
matory agents, anti-tumour agents and radio- and chemosensi-
tizers (Stanley and Rotrosen, 1982; Robert-Piessard et al, 1990;
Rang and Urban, 1995; Pero et al, 1998). Variants of the drugs
have been shown to have several targets like DNA repair, blood
micro-circulation, dopamine and hydroxy-tryptamine receptors,
and also to induce DNA damage and apoptosis (Stanley and
Rotrosen, 1982; Robert-Piessard et al, 1990; Rang and Urban,
1995; Pero et al, 1998). Here, we have investigated the
radio/chemo-sensitizing properties of N-substituted benzamide
analogues of procainamide. We show that the addition of a
chloride to the procainamide aromatic ring structure converted this
compound to an apoptosis-inducing agent that also inhibited
NFkB activation. The NFkB inhibition could be further potenti-
ated by a N-acetyl substitution that simultaneously blocked the
apoptotic effect, indicating that these functions were independent
of each other. In accordance with this, the addition of an aromatic
N-acetyl group to the procainamide aromatic ring sufficed to
create an inhibitor of NFkB activation also in the absence of
a chloride substitution. These findings point to two possible mole-
cular mechanisms for the radio/chemo-sensitizing effects of
N-substituted benzamides and they are also pertinent for the
development of NFkB inhibitory drugs.
MATERIALS AND METHODS
Drugs
Procainamide, N-acetyl procainamide, metoclopramide, N-acetyl
metoclopramide, declopramide and N-acetyl declopramide were
supplied as purified and structurally elucidated hydrochloride salts
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dissolved in physiological saline for addition to cell cultures.
Cell culture
Cells (70Z/3) were grown in Iscoves modified Dulbecco’s medium
supplemented with 7.5% fetal calf serum (FCS), 50 mM
2-mercaptoethanol, fungizone and gentamycine (Gibco). Lipo-
polysaccharide (LPS) (Difco, Escherichia coli 055:B5) was added
at 25 mg ml–1 where indicated.
Cell staining and flow cytometry
Cells (70Z/3) were harvested and washed once in phosphate-
buffered saline (PBS). All stainings were performed on ice in
Hank’s balanced salt solution with 10 mM HEPES buffer, 3% FCS
and 0.1% azide. The following commercially supplied reagents
were used for staining: 7AAD (Sigma), Annexin V-FITC (fluore-
scein isothiocyanate; Trevigen) and streptavidin–PE (Southern
Biotechnology). As an anti-Igk reagent a monoclonal rat anti-
mouse k (187.1) that had been biotinylated was used and prior to
staining with this reagent the cells were treated with a monoclonal
anti-Fc receptor antibody (24G2) for 15 min. All analyses were
performed in a Becton Dickinson FACSorter using the Cell Quest
software package. One representative experiment out of at least
three performed is shown where not otherwise stated.
Nuclear extracts and electrophoretic mobility shift
assay
Nuclear extracts from 2.5 ´ 106 cells were made according to
Schreiber et al (1989). Electrophoretic mobility shift assay
(EMSA) was performed as previously described (Liberg et al,
1998). In brief, protein was mixed with 1 mg poly-dI-dC
(Pharmacia) and 20 000 cpm of 32P end-labelled probe in Bind
buffer (20 mM sodium phosphate buffer pH 6.0, 10 mM magne-
sium chloride (MgCl2), 0.1 mM EDTA, 2 mM dithiothreitol, 0.01%
NP-40, 0.1 mM sodium chloride (NaCl), 100 mg ml–1 bovine serum
albumin and 4% Ficoll). The samples were incubated for 30 min at
room temperature and separated on a 5% polyacrylamide gel.
Western blotting
Cytoplasmic extracts were made from 1 ´ 106 cells by adding
100 ml of lysis buffer (75 mM Tris pH 8, 100 mM NaCl, 5 mM
potassium chloride (KCl), 3 mM MgCl2, 2% NP-40 and 0.1 mM
phenylmethyl sulphonyl fluoride (PMSF)) and incubating on ice
for 5–10 min. The nuclei were pelleted by centrifugation and the
supernatants frozen in aliquots at –80°C. A total of 5–10 ml of the
extracts were fractionated by sodium dodecyl sulphate polyacryl-
amide gel electrophoresis (SDS-PAGE) and transferred to a nylon
membrane (Hybond-C extra; Amersham). Polyclonal antibodies
specific for IkBb were obtained from Santa Cruz (sc-945).
Secondary horseradish peroxidase (HRP)-conjugated antibodies
and chemiluminescence ECL reagents were from Amersham. The
membranes were blocked for 20 min in PBS-T (PBS and 0.05%
Tween-20) with 5% skimmed milk, after which primary antibodies
were added in the same buffer. The membranes were washed for
3 ´ 5 min in PBS-T, after which the secondary antibodies were
added again in PBS-T with milk. The membranes were washed as
above, and the chemiluminescence reaction was performed
according to the manufacturer’s protocol.
RESULTS
Rapid induction of apoptosis by N-substituted
benzamides
To analyse the effects of N-substituted benzamides we synthesized
a set of benzamide hydrochloride salt derivatives using
procainamide (PA) as a basic structure. These analogues are
shown in Figure 1 together with the abbreviations used throughout
this paper. In all analogues the side-chain was kept unaltered while
various active groups were added to the ring structure. Some of
these molecules, e.g. declopramide (3-CPA) and metoclopramide
(MCA) have previously been studied in vitro, in vivo and in clin-
ical models (Kjellen et al, 1989, 1995; Lybak et al, 1990; Lybak
and Pero, 1991; Hua et al, 1995, 1997; Werning et al, 1995; Hua
and Pero, 1997; Olsson et al, 1997; Pero et al, 1998), and have
been shown to be biologically active.
Our in vitro model in this study was the well-characterized
murine pre-B-cell line 70Z/3 (Paige et al, 1978; Perry and Kelley,
1979). This cell line contains a silent but functionally rearranged
immunoglobulin (Ig) k locus that will be transcribed upon nuclear
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Figure 2 (A) Experimental setup for apoptosis analysis. The figure shows an example of analysis of 70Z/3 cells treated with 500 mM 3-CPA for 20 h. The
7AAD negative (viable) cells were gated (gate A) and analysed for AnnexinV expression. (B) Decrease in viable cell number (7AAD–) and increase in apoptosis
induction (7AAD–/AnnexinV+) after treatment of 70Z/3 cells with the indicated drugs for 20 h. (C) A caspase 1, 3 and 4 inhibitor (ZVADfmk) counteracts
apoptosis induction of 3-CPA. Cells were pretreated with ZVADfmk for 1 h before addition of 500 mM of the indicated drugs and further incubation for 17 h. The
graphs show relative viability (%7AAD– of drug-treated cells/%7AAD– of untreated cells) and relative AnnexinV staining (%AnnexinV+7AAD– of drug-treated
cells/% AnnexinV+7AAD– of untreated cells) for each concentration of ZVADfmk. One representative experiment out of 2 is showntranslocation of the NFkB transcription factor (Paige et al, 1978;
Rosoff et al, 1984; Rosoff and Cantley, 1985; Sen and Baltimore,
1986 and below). For the detection of viable cells we used the vital
dye 7-amino-actinomycin D (7AAD). With this reagent viable
cells are 7AAD–, while 7AAD+ cells tend to be distributed in two
separate populations. The brightest staining population corre-
sponds to necrotic/late apoptotic cells while the population with
intermediate fluorescence intensity corresponds to apoptotic cells
(Schmid et al, 1994; Philpott et al, 1996). To quantitate early
apoptosis we also measured the percentage of AnnexinV-positive
cells in the 7AAD– population (Koopman et al, 1994). AnnexinV
recognizes phosphatidyl serine, which is exposed on the cell
surface early during apoptosis due to loss of membrane asym-
metry. Thus, using this approach we can obtain two independent,
quantitative measurements of apoptosis from the same sample.
The assay system is illustrated in Figure 2A for untreated and
3-CPA treated 70Z/3 cells.
We next investigated the effects of the different benzamide
derivatives on induction of apoptosis in 70Z/3 cells. The data after
20 h of treatment are shown in Figure 2B. Both the percentages of
7AAD– (viable) cells and of AnnexinV-positive cells in the
7AAD– cell population (early apoptotic cells) are indicated. As
predicted, an inverse correlation between these two parameters
could be observed. With regard to the benzamides, no induction of
apoptosis could be detected by PA. The addition of one chloride
atom to the 3¢ position of the benzamide ring resulted in a
compound (3-CPA) that showed a dose-dependent, pro-apoptotic
effect on 70Z/3 cells from 250 to 500 mM concentration. This
finding supports previous investigations where the pro-apototic
effect of N-substituted benzamides on HL-60 and K562 cells were
investigated (Pero et al, 1998). The addition of a methoxy group to
the 2¢ position of the benzamide ring structure together with the
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Table 1
Treatment at day 0 % 7AAD– cells
Day 1 Day 2 Day 3
None 92 84 73
500 mM PA 92 87 78
500 mM Na-3-CPA 92 89 81
Na-3-CPA did not induce delayed apoptosis in 70Z/3 cells. 70Z/3 cells were
incubated with the indicated compounds and analysed for the induction of
cell death using the 7AAD vital dye at the indicated time points. One
representative experiment out of two is shown.
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Figure 3 (A) Experimental setup for analysis of Igk inhibition. 70Z/3 cells were treated with drugs for 5 h before LPS addition and for another 19 h before
analysis. 7AAD– cells were gated for as in Figure 2A analysed for expression of surface Ig. Also shown in the Figure is a band-shift analysis using nuclear
protein extracts made from unstimulated and LPS-stimulated 70Z/3 cells and an octamer or a NFkB binding site probe. (B) Inhibition of surface Ig expression on
70Z/3 cells by different N-substituted benzamides. The drugs were added 5 h before LPS addition and incubation was continued for 19 h before analysis.
(C) N-acetylation of procainamide mediates inhibition of LPS-induced surface Ig on 70Z/3 cellschloride and amino substitutions already present in 3-CPA (MCA)
did not modify this pro-apoptotic activity. However, the addition
of an acetyl group to the 4¢ amino group on the benzamide ring
(Na-3-CPA; Na-MCA) completely abolished the pro-apoptotic
effect of the chloride substitution. Also, PA with the addition of the
acetyl group was completely inactive with regard to apoptosis
induction (data not shown). To exclude the possibility that
Na-3-CPA would induce apoptosis in 70Z/3 cells with different
kinetics than 3-CPA, we performed an experiment where we moni-
tored the induction of cell death over a 3-day interval. As shown in
Table 1, Na-3-CPA did not increase the number of 7AAD+ cells at
any of these time points. We conclude from these results that the
addition of a chloride atom next to an amino group in the benz-
amide ring structure correlates with the biological activity as an
inducer of rapid apoptosis in 70Z/3 cells. The addition of an acetyl
group on the neighbouring aromatic amino group will obliterate
this effect.
To further analyse the mechanism of apoptosis induction, we
repeated the declopramide experiment in the presence and absence
of a caspase 1, 3 and 4 inhibitor (benzyloxycarbonyl-valinin-
alaninyl-aspartyl fluoromethyl ketone (ZVADfmk) (Thornberry
et al, 1992; Dolle et al, 1994) (Figure 2C). This caspase inhibitor
reduced the induction of apoptosis caused by 3-CPA significantly
both when measured as the induction of 7AAD+ or AnnexinV+
cells. Thus, the apoptosis-induction activity of 3-CPA involved the
activation of at least one of these caspases.
Inhibition of NFkB activation by N-substituted
benzamides
The NFkB signalling pathway has been shown to be able to
salvage cells from apoptotic cell death in some experimental
systems (Beg and Baltimore, 1996; Liu et al, 1996; Van Antwerp
et al, 1996; Wang et al, 1996; Wu et al, 1996). The 70Z/3 cell line
has been used extensively to study NFkB activation, and we hence
proceeded to investigate the effect of the benzamide derivatives on
NFkB activation. As mentioned above, this cell line has a recom-
bined but transcriptionally silent immunoglobulin k locus, the
expression of which can be induced by activators of NFkB such as
lipopolysaccharide (LPS) (Paige et al, 1978; Sen and Baltimore,
1986). Ig light-chain expression will lead to assembly of a
complete Ig molecule that will be expressed on the cell surface,
and therefore, surface staining of 70Z/3 cells for Ig expression
presents a convenient measurement for NFkB activation. A typical
experiment is shown in Figure 3A. Again, we measure only the
surface Ig expression on live cells as defined by lack of 7AAD
staining. Analysis of this gate in unstimulated 70Z/3 cells showed
that virtually 100% of the cells are negative for surface Ig staining.
However, after stimulation overnight with 25 mg ml–1 LPS,
approximately half of the cells were surface positive for Ig, which
correlated with nuclear expression of NFkB as determined by
band-shift analysis.
We then proceeded to investigate the effect of the benzamide
derivatives on NFkB activation using this assay. The cells were
preincubated with different concentrations of the drugs for 5 h, and
subsequently LPS was added for an additional 19 h. The cells were
stained with 7AAD and anti-Igk and the number of 7AAD–k+ cells
were quantified. As in the apoptosis assay, PA was completely
inactive with regard to inhibition of NFkB induction while the
chloride-containing variants (3-CPA and MCA) inhibited approxi-
mately 50% of the LPS-induced surface Ig (Figure 3B). More
importantly, the acetylated variants (Na-MCA, Na-3-CPA), that
were essentially inactive in the apoptosis assay, were even more
active on a molar basis, and more or less abolished induction of
surface Ig at 1 mM concentration.
Although PA had essentially no NFkB inhibitory activity,
the chloride substituted analogues had some activity (3-CPA
and MCA) whereas the acetylated plus chloride-substituted
Mechanisms of N-substituted benzamide action 985
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Figure 4 The kinetics of surface Ig expression on 70Z/3 cells after LPS stimulation correlates with the kinetics of IkBb degradation. Cytoplasmic extracts were
prepared, equalized by Coomassie staining and probed for IkBb in Western blots. Inclusion of 500 mM MCA, Na-3-CPA or Na-Pa in the cultures inhibited IkBb
breakdown while addition of PA did notbenzamides (Na-3-CPA and Na-MCA) were more potent with
regard to inhibition of NFkB activation. These data suggested that
the N-acetyl group in itself could be an active site for NFkB
inhibition also in the absence of the chloride substitution. A
prediction from this structure/function analysis was that N-acetyl
PA, having no chloride substitution (Figure 1), should inhibit
surface Ig induction in 70Z/3 cells. Indeed, as shown in Figure 3C,
the addition of an aromatic N-acetyl group to PA converted this
inactive molecule to a potent inhibitor of NFkB activation. We
conclude from these experiments that N-substituted benzamides
can be converted to potent inhibitors of NFkB activation if an
aromatic N-acetyl group is appropriately introduced.
N-substituted benzamides inhibit IkBb degradation in
70Z/3 cells
We next wanted to confirm the effect on NFkB activation by
N-substituted benzamides at the biochemical level. The NFkB
proteins are sequestered in the cytoplasm by IkB molecules
(reviewed in Whiteside and Israel, 1997; Ghosh et al, 1998), in
70Z/3 cells mainly by IkBb (Whiteside et al, 1997). IkBa and
IkBb interact with the same combinations of Rel-proteins,
predominantly p50:p65 and p50:c-Rel complexes (Thompson
et al, 1995; Whiteside et al, 1997), but they differ in the kinetics of
their breakdown and in the signals to which they respond. While
IkBa responds to all known inducers of NFkB, IkBb is only
affected by some, like LPS and IL-1 (Thompson et al, 1995). In
addition, while IkBa is phosphorylated and broken down rapidly
after stimulation, IkBb follows a somewhat slower kinetics
(Thompson et al, 1995; DiDonato et al, 1996). Furthermore, the
IkBa gene is itself a target for NFkB and is thus rapidly resynthe-
sized after NFkB activation (de Martin et al, 1993; Le Bail et al,
1993), while IkBb levels remain low as long as the signal remains
(Thompson et al, 1995). Given this background information, we
concentrated on the effects of benzamide treatment on IkBb. As
shown in Figure 4 the kinetics of induction of surface Ig and IkBb
breakdown, as measured by Western blotting, after LPS treatment
correlated favourably. If the cells were treated with 500 mm MCA
the LPS-induced IkBb breakdown was inhibited. This finding was
also confirmed using Na-3-CPA and Na-PA where both were seen
to inhibit IkBb breakdown. Hence, both the chloride substitution
and the N-acetyl group addition to the PA backbone resulted in
compounds that inhibited IkBb breakdown.
DISCUSSION
In this report we show that N-substituted benzamides can induce
rapid apoptosis as well as inhibit NFkB activation in target cells.
We also show that altering the substitutions on the benzamide ring
structure can skew the biological activity of the benzamides either
towards apoptosis-promoting activity or NFkB inhibitory activity.
These findings explain the mechanisms involved in the biological
activity of N-substituted benzamides as radio/chemo-sensitizers.
Furthermore, our data also point to the possibility for a rational
design of benzamide analogues that show a high selectivity with
regard to biological activities. Since N-substituted benzamides
have been in clinical use for many years (Stanley and Rotrosen,
1982), such compounds would be promising candidates to be
developed for clinical use.
We have first confirmed previous investigations (Pero et al,
1998) with regard to the apoptosis-induction abilities of the
N-substituted benzamides. We were able to show that while PA
was completely inactive in this assay, MCA and 3-CPA were both
potent inducers of apoptosis in the 500 mM concentration range.
The activity was completely inhibited by the addition of a caspase
1, 3 and 4 inhibitor, showing that the mechanism of action
involved is an early activation of caspases. The biological activity
was dependent on a single aromatic chloride substitution on the
benzamide ring which distinguishes 3-CPA from PA, whereas the
methoxy group that distinguishes MCA from 3-CPA was inert
with regard to apoptosis induction. This is interesting since MCA
is already used in the clinic as an antiemetic with both local and
systemic effects (Harrington et al, 1983). Furthermore, both MCA
and 3-CPA have been implicated as potential sensitizers of
radio/chemo-therapies and phase 1–3 clinical trials are in progress
(Kjellen et al, 1989, 1995; Lybak et al, 1990; Lybak and Pero,
1991; Hua et al, 1995, Werning et al, 1995; Hua and Pero, 1997).
Whether this in vivo activity is due to the ability of direct induc-
tion of apoptosis by MCA or 3-CPA, or correlates with their ability
to inhibit NFkB activation, remains to be established. Lastly, the
addition of the aromatic amino group interferes with the apoptosis-
inducing ability of both MCA and 3-CPA. We prefer to interpret
this observation by steric hindrance rather than induction of an
opposing mechanism, but this assumption remains to be tested
experimentally.
Beside their ability to induce apoptosis directly in HL-60 and
K562 human leukaemia cell lines (Pero et al, 1998), MCA and 3-
CPA have also been shown to inhibit tumour necrosis facter a
(TNF-a) production in vivo after LPS administration and the
expression of a NFkB reporter gene construct in HeLa cells (Pero
et al, 1999). Based on this information we investigated the possi-
bility that these drugs might interfere with the NFkB activation
pathway. Indeed, both MCA and 3-CPA inhibited NFkB activation
measured as the induction of surface Ig on 70Z/3 cells. However,
even at the highest concentrations of these drugs tested the inhibi-
tion was not complete and the potent induction of apoptosis made
it impossible to further increase the concentrations. Interestingly,
the induction of apoptosis in 70Z/3 cells by MCA or 3-CPA did
not by itself activate the NFkB salvage pathway (Beg and
Baltimore, 1996; Liu et al, 1996; Van Antwerp et al, 1996; Wang
et al, 1996; Wu et al, 1996), a feature that might be pertinent for
the utilization of these drugs in tumour treatment (data not shown).
Adding an N-acetyl group to 3-CPA, creating Na-3-CPA, greatly
enhanced the potency of the inhibitory capacity on NFkB activa-
tion where complete inactivation of NFkB activity was achieved at
1m M concentration. The importance of the N-acetyl substitution
was confirmed by using Na-MCA in our assay, and even more
importantly by the utilization of Na-PA. Hence, the addition of an
aromatic chloride to PA creates a compound with caspase activa-
tion potential, while the addition of an aromatic N-acetyl substitu-
tion converts it to a potent inhibitor of NFkB activation. Because
Na-PA and not PA showed high NFkB inhibitory activity, the
partial inhibitory activity of NFkB activation seen by MCA and
3-CPA is puzzling. It could be argued that the aromatic chloride
substitution adjacent to an aromatic amino substitution could
partially replace the conformational specificity of the aromatic
N-acetyl substitution at the putative active binding site and hence
mediate partial NFkB inhibitory activity. Again, further experi-
mentation is needed to clarify this issue.
With regard to the mechanism of action of the benzamides on
NFkB activation we have shown that the compounds act at an
early stage by inhibiting IkBb breakdown. The early activation
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recent years. A high molecular weight protein complex has been
described that contains two IkB-specific kinases (Chen et al, 1996;
Lee et al, 1997), as well as other accessory proteins that are neces-
sary for proper NFkB activation (Chen et al, 1996). The action of
the N-substituted benzamides prior to IkB breakdown places their
presumptive ligand upstream in the NFkB activation pathway.
The pharmaceutical potential of the compounds described
herein is significant. With regard to tumour therapy it can be envi-
sioned that different tumours show different sensitivity for the
apoptosis-inducing activity of the benzamides, as well as rely to a
various extent on NFkB mediated salvage from apoptosis (Pero
et al, 1998, 1999). Hence, the selective use, or combination of,
benzamides that have selective properties with regard to these
biological pathways may increase the efficacy of treatment of
malignant disease together with conventional therapies. Lastly, the
inhibition of NFkB activation mediated by the N-substituted
benzamides may open a possibility for their development in
treatment of inflammatory diseases.
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